CDH1 and breast carcinoma: In studies on breast cancer, ovarian cancer and pancreatic cholangiocarcinoma, P300 is poorly expressed and played an important role in inhibiting EMT and sustaining E-cadherin expression in tumor cells through the regulation of P300-targeted miRNAs23–26.